Neuronal calcium-binding proteins and schizophrenia

Schizophrenia Research

Volumn 57, Issue 1, 2002, Pages 27-34

  Eyles, D W ^a,b   McGrath, J J ^a   Reynolds, G P ^c  

^a WOLSTON PARK HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Calbindin; Calcium binding proteins; Calretinin; Neuropathology; Parvalbumin; Schizophrenia

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN;

ARTICLE; BRAIN REGION; CELL SUBPOPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTERNEURON; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; GAMMA-AMINOBUTYRIC ACID; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; INTERNEURONS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 0036723429     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00299-7     Document Type: Article

References (56)

1. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: Lack of evidence for a neuroprotective role of endogenenous calbindin in MPTP-treated and weaver mice
2. Calcium-binding proteins: Selective markers of nerve cells
3. Calcium binding proteins in the nervous system
4. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
5. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain
6. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus
7. Quantitative cytoarchitectural analyses of the cerebral cortex of schizophrenics
8. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
9. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
10. Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells
11. Introduction to EF-hand calcium binding proteins
12. Regulation of excitatory transmission at hippocampal synapses by calbindin D28K
13. Vitamin D-dependent calcium binding proteins: Chemistry, distribution, functional considerations, and molecular biology
14. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: Distribution and morphology
15. No alterations in the density of parvalbumin or calretinin immunoreactive neurons in the anterior cingulate cortex (BA 24b/c) in schizophrenia or bipolar disorder
16. Schizophrenia and anteroventral thalamic nucleus: Selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons
17. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons
18. Calcium regulation of apoptosis
19. Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes
20. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia
21. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory
22. Functional and anatomical aspects of prefrontal pathology in schizophrenia
23. The neuropathology of schizophrenia: A critical review of the data and their interpretation
24. 2+-binding proteins in human neurodegenerative disorders
25. 28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity
26. Distribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and human
27. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases
28. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease
29. Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics
30. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex
31. Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients
32. 28K (CaBP) levels and calcium currents in acutely dissociated epileptic neurons
33. Could the interaction of neuroleptics with calmodulin be an "explanation" of the psychotropic effects?
34. Subpopulations of cortical GABAergic interneurons differ by their expression of D1 and D2 dopamine receptor subtypes
35. Chandelier cells: Shedding light on altered cortical circuitry in schizophrenia
36. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia
37. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro
38. Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics
39. 28K in cultured hippocampal neurons
40. 28K
41. Glutamate receptor dysfunction and schizophrenia
42. NMDA receptor hypofunction model of schizophrenia
43. GABAergic neuronal subtypes in the human frontal cortex- development and deficits in schizophrenia
44. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: Selective losses of calcium binding protein immunoreactivity
45. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation
46. Chronic antipsychotic drug administration alters calcium-binding protein levels but not GAD levels in the prefrontal cortex of the rat
47. Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17
48. Axon terminals immunolabeled for dopamine or tyrosinehydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex
49. 28K) and parvalbumin immunocytochemistry: Localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity
50. 2+-permeable AMPA/kainite receptors
51. Calmodulin in brain of schizophrenics
52. A candidate molecule approach to defining developmental pathology in schizophrenia
53. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons
54. A subclass of prefrontal Gama-aminobutyric acid axon terminals are selectively altered in schizophrenia
55. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia